Rapidx

Company Overview

Snapshot

Founded in January 2008 by Idan Tamir, Rapidx operated with 1–10 employees. The company raised $1 million across two funding rounds from two investors. In July 2008, Rapidx secured seed funding from Medvest and TechnoPlus Ventures.

Business overview

Rapidx developed self-administered rapid blood diagnostic tests designed for discreet home use across various health conditions. The company's core technology integrated the lancet, blood collection, and rapid diagnostic test into a single, affordable, and disposable device. Rapidx aimed to serve the growing point-of-care and homecare markets, addressing the pain and contamination risks associated with traditional blood lancing processes. The company operated within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Digital Healthcare.

Company Intelligence Q&A

What is Rapidx's primary focus?

Rapidx specializes in developing self-administered rapid blood diagnostic tests for at-home use, aiming to provide discreet and convenient solutions for various health conditions.

When was Rapidx founded?

Rapidx was founded in January 2008.

Who is a notable founder of Rapidx?

Idan Tamir is a founder of Rapidx.

What was a key technological advancement by Rapidx?

Rapidx developed a proprietary technology that integrates the lancet, blood collection, and rapid diagnostic test into one affordable, completely disposable device, addressing issues of pain and contamination in blood extraction.

What was the outcome of Rapidx's clinical trial?

Rapidx completed a clinical trial at Tel Aviv Medical Center with 30 volunteers, which demonstrated faster blood extraction and less pain compared to the gold-standard technique performed by nurses. This led to the company registering an FDA 510(k) patent on the novel component of its blood extraction process.